Clinical Trial Update: CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)

View source ↗

Summary

The clinical trial of certolizumab pegol (CDP-870) in adults with Crohn's disease is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Crohn's Disease | Status: NO_LONGER_AVAILABLE